DATASHEET
Host:
Rabbit
Target Protein:
GCNT1
Immunogen Range:
201-260/428
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
2650
Source:
KLH conjugated synthetic peptide derived from human GCNT1
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
GCNT1 is expressed in a variety of cell types, including lymphocytes and mucin-producing cells. Specifically, GCNT1 expression in leukocytes regulates the synthesis of core 2 O-glycans that carry sialyl-Lewis x (sLex) oligosaccharides, which confer high affinity binding to Selectins. Downregulation of Selectin ligand expression levels has been shown to inhibit tissue infiltration. Therefore, GCNT1 represents a potential drug target for the treatment of inflammatory disorders and other pathologies involving Selectins.
VALIDATION IMAGES
Lane 1: Cerebrum lysates probed with GCNT1 Polyclonal Antibody, Unconjugated (bs-12334R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: U87MG cell lysates probed with GCNT1 Polyclonal Antibody, Unconjugated (bs-12334R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Rat Lymph node tissue lysates; Lane 2: Human SW480 cell lysates; Lane 3: Human TT cell lysates; Lane 4: Human U87MG cell lysates; Lane 5: Human MCF-7 cell lysates probed with GCNT1 Polyclonal Antibody, Unconjugated (bs-12334R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.